Management of Severe Dysmenorrhea

Pharmacologic Interventions

The American Academy of Pediatrics recommends combined oral contraceptives as a second-line treatment for dysmenorrhea, with evidence showing a pooled OR of 2.01 (95% CI 1.32-3.08) for pain relief compared to placebo, and both low-dose and medium-dose estrogen formulations are effective 1
Extended or continuous cycles of combined oral contraceptives (21-24 days of active pills followed by immediate start of new pack) can reduce or eliminate menstrual periods entirely, which may be particularly beneficial for severe dysmenorrhea, according to the American Academy of Pediatrics and other guideline societies 1, 2

The guideline society recommends initiating NSAID therapy (ibuprofen 400mg every 4-6 hours or naproxen 500mg twice daily) starting one day before expected menses, and adding combined oral contraceptives if NSAIDs alone provide insufficient relief after 2-3 menstrual cycles 1
Consider extended or continuous OCP regimens (skipping placebo pills) to reduce frequency of menstrual periods and associated pain, as suggested by the American Academy of Pediatrics and other guideline societies 1, 2

Combined oral contraceptives (COCs) should be added as second‑line treatment when NSAIDs do not provide adequate relief after 2–3 menstrual cycles. 3

Both low‑dose (20–35 µg ethinyl estradiol) and medium‑dose COC formulations are effective for reducing dysmenorrhea pain. 3

Before prescribing COCs, clinicians must screen for contraindications such as severe hypertension (≥160/100 mmHg), migraine with aura, a history of thromboembolism, or thrombophilia. 3

When transitioning to an extended or continuous COC regimen, no additional backup contraception is required as long as the patient continues taking active pills daily. 4